Status:
NOT_YET_RECRUITING
Treatment and Handling Severe Obesity-Related Comorbidities in Adolescents Through Exercise
Lead Sponsor:
University of Lisbon
Collaborating Sponsors:
Lusofona University
Conditions:
Adolescent Obesity
Hypertension,Essential
Eligibility:
All Genders
13-18 years
Phase:
NA
Brief Summary
The main objective of this project is to analyze the effect of a tailor-made, one-to-one, exercise program (aiming to treat and handle obesity-related comorbidities in adolescents with severe obesity ...
Detailed Description
The THOR-X project is designed as a series of n-of-1 trials, with a crossover methodology. Each trial will include 3 phases and 5 assessment times organized as follows: Phase 1. Retrospective phase. ...
Eligibility Criteria
Inclusion
- adolescents aged 13 to 18 years;
- of any gender (including transgender adolescents);
- with severe obesity (≥3.0 BMI z-score) \[24\];
- with any obesity-related comorbidity (e.g., hypertension, IR or DMT2, dyslipidemia, eating disorders, depression/anxiety);
- at least 6 months of follow-up at the Pediatric Obesity Clinic (HSM, CHULN) at the time of recruitment;
- living in Lisbon area;
- informed consent/assent signature.
Exclusion
- major or unstable clinical conditions (other than obesity or its related comorbidities);
- inability to perform regular PA;
- pregnancy;
- mental disorders;
- smoking habits;
- being involved in another weight loss program.
Key Trial Info
Start Date :
January 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT06520800
Start Date
January 1 2025
End Date
December 1 2028
Last Update
July 29 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.